Forkhead box protein C1 (FOXC1)

Forkhead box protein C1 (FOXC1) is a nuclear protein transcription factor that belongs to the forkhead box (FOX) family. It contains a highly conserved forkhead (winged-helix) DNA-binding domain, which enables FOXC1 to regulate the transcription of diverse gene sets involved in embryogenesis, cardiovascular development, and ocular formation[1][2][3][4]. FOXC1 is critical for proper mesodermal and neural crest development, heart morphogenesis, segmentation, and eye anterior segment formation. Mutations in FOXC1 cause Axenfeld-Rieger syndrome and are implicated in Dandy-Walker malformation[2][3][4]. Aberrant FOXC1 expression is associated with cancer cell proliferation, stemness, migration, and angiogenesis; its expression is regulated by multiple signaling pathways, including NF-κB, EGFR/MAPK, and PI3K/Akt pathways[1][2]. Recent studies highlight FOXC1 as a potential biomarker and emerging therapeutic target in diverse carcinomas, though direct inhibitors have not yet been clinically approved[1][2].

Other names

FKHL7FREAC3FREAC-3ARAIGDAIHG1IRID1RIEG3forkhead box C1 proteinforkhead/winged helix-like transcription factor 7myeloid factor-delta

Agents targeting EGFR, MAPK/ERK, or PI3K/Akt pathways may lower FOXC1 activity by reducing mRNA/protein expression. Hypothetical future FOXC1 inhibitors would act via transcriptional repression or inhibition of DNA binding.